Toxicity evaluation of inorganic nanoparticles: considerations and challenges
- First Online:
- Received:
- Accepted:
DOI: 10.1007/s13273-013-0026-z
- Cite this article as:
- Choi, SJ., Lee, J.K., Jeong, J. et al. Mol. Cell. Toxicol. (2013) 9: 205. doi:10.1007/s13273-013-0026-z
- 17 Citations
- 812 Downloads
Abstract
Toxicity evaluation of inorganic nanoparticles in cell lines and in whole animals has been extensively explored in recent years. However, conflicting results have been reported regarding size-dependent toxicity and biokinetics in vitro and in vivo, and thus, basic questions regarding whether nanoparticles, ranged from 1 to 100 nm in size, are comparatively more toxic than larger-sized particles remain unanswered. This may be closely associated with changes in physicochemical properties of nanoparticles in biological fluids. Understanding in vivo physiological barriers, biological fates, and absorption mechanism of nanoparticles upon exposure routes will be useful to predict their toxicity potential. This review will highlight the critical points to be considered in order to evaluate the toxicity of inorganic nanoparticles, and discuss the issues and challenges emerging in the field of nanotoxicology.